Science and Technology International Development
2021-01-19
TAGS
Response quality
Questions & Answers
Q1
Direct Answer
▸
Context
The question arises from the recognition that UK-funded scientific advancements have significantly contributed to reducing poverty, improving child mortality rates, and increasing life expectancy globally.
What steps he is taking to ensure UK science and technology plays a role in international development. Scientific advances funded by the UK have helped drive reductions in extreme poverty, declines in childhood mortality and increases in life expectancy across the developing world.
Scientific advances funded by the UK have helped drive reductions in extreme poverty, declines in childhood mortality and increases in life expectancy across the developing world. Our investments, including in affordable rapid diagnostic tests for covid-19 and the world's first child-friendly antimalarial drug, are delivering benefit to hundreds of millions. We will continue to leverage UK and global scientific excellence and invest in cutting-edge technology and research to provide solutions to critical development challenges.
▸
Assessment & feedback
Response accuracy
Q2
Direct Answer
▸
Context
The context involves the successful vaccine rollout in the UK, with a particular focus on the potential of the AstraZeneca vaccine for use in developing nations. There is also recognition that developing countries need robust healthcare infrastructure to effectively roll out vaccines.
Will the Minister say at what point we will pass vaccines that we have ordered that greatly surpass the need of our population to COVAX? Does he agree that it is vital that, in advance of that, we do everything in our power to develop healthcare infrastructure in developing countries, without which a credible vaccine roll-out is just not possible?
I thank my right hon. Friend for his question. I agree that we should be incredibly proud of the work that we have done with regard to the vaccine. I have had meetings with my Philippine counterparts on vaccines, alongside AstraZeneca. We are supporting equitable access through our funding for the COVAX facility. We are one of the largest donors to the COVAX advance market commitment to support access for 92 developing countries; we have committed £548 million. COVAX's partners, which include Gavi, the World Health Organisation and UNICEF, have huge experience in supporting developing country immunisation systems and the programming of immunisation. We expect the initial roll-out to COVAX AMC countries to start in the first quarter of this year.
▸
Assessment & feedback
Response accuracy